Nutritional status alterations after chimeric antigen receptor T cell therapy in patients with hematological malignancies: a retrospective study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
https://link.springer.com/content/pdf/10.1007/s00520-021-06639-2.pdf
Reference39 articles.
1. Mullard A (2017) FDA approves first CAR T therapy. Nature Reviews Drug Discovery 16(10):669–669. https://doi.org/10.1038/nrd.2017.196
2. Mullard A (2017) Second anticancer CAR T therapy receives FDA approval. Nature Reviews Drug Discovery 16(12):818–818. https://doi.org/10.1038/nrd.2017.249
3. Ma S et al (2019) Current progress in CAR-T cell therapy for solid tumors. Int J Biol Sci 15(12):2548–2560
4. Lin WY et al (2020) Gene modified CAR-T cellular therapy for hematologic malignancies. Int J Mol Sci 21(22):8655
5. Park JH et al (2018) Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N Engl J Med 378(5):449–459
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma;Nature Communications;2024-06-18
2. Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy;BMC Cancer;2023-11-02
3. A patient and public involvement (PPI) review exploring patient reported outcome measures in adult CAR T-cell therapy patients;Clinical Nutrition Open Science;2023-10
4. The nutritional impact of CD19‐targeted CAR‐T therapy versus BEAM chemotherapy for adult patients with lymphoma;Journal of Human Nutrition and Dietetics;2023-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3